According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...

New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.

Metformin is the main first-line drug used to treat type 2 diabetes, but a new study on monkeys suggests it could one day be ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study ...

Children who used the weight loss drug liraglutide in a late-stage trial lost significantly more weight than children who got ...

While the link between diabetes and periodontal disease is known, the impact of diabetes treatment on periodontal health is ...

Metformin, a common medication used to treat type 2 diabetes, may also help reduce the viral reservoir in people living with ...

Novo Nordisk has multiple, strong upcoming, positive catalysts, related to its GLP-1 weight-loss drugs, Ozempic and Wegovy.

In late June, generic drug maker Teva Pharmaceuticals launched a generic version of Victoza, a blockbuster diabetes drug, in ...

The U.S. healthcare system, built on binary disease definitions, is not prepared to handle the complexities of weight loss coverage.

A recent study reveals that intensive diabetes treatment can improve periodontal disease inflammation. Researchers found that two weeks of intensive diabetes treatment under hospitalization for ...

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...